The impact of asthma, chronic bronchitis and allergic rhinitis on all-cause hospitalizations and limitations in daily activities: a population-based observational study

• Simone AccordiniEmail author,
• Angelo Guido Corsico,
• Lucia Calciano,
• Roberto Bono,
• Isa Cerveri,
• Alessandro Fois,
• Pietro Pirina,
• Roberta Tassinari,
• Giuseppe Verlato and
• Roberto de Marco

BMC Pulmonary Medicine201515:10

DOI: 10.1186/s12890-015-0008-0

Open Peer Review reports

Abstract

Background

Chronic respiratory diseases are a significant cause of morbidity and mortality worldwide. We sought to evaluate the impact of asthma, chronic bronchitis and allergic rhinitis on all-cause hospitalizations and limitations in daily activities in adults.

Rhinitis- a Primer for Specialists (Prof. Mark Dykewicz)

Conferences Online Allergy (COLA)

ACAAI

Drug allergy passport and other documentation for patients with drug hypersensitivity – An ENDA/EAACI Drug Allergy Interest Group Position Paper

Allergy

Accepted Article (Accepted, unedited articles published online and citable. The final edited and typeset version of record will appear in future)

1. K. Brockow^1,*, 
2. W. Aberer², 
3. M. Atanaskovic-Markovic³, 
4. S. Bavbek⁴, 
5. A. Bircher⁵, 
6. B. Bilo⁶, 
7. M. Blanca⁷, 
8. P. Bonadonna⁸, 
9. G. Burbach⁹, 
10. G. Calogiuri¹⁰, 
11. C. Caruso¹¹, 
12. G. Celik¹², 
13. J. Cernadas¹³, 
14. A Chiriac¹⁴, 
15. P. Demoly¹⁴, 
16. J.N.G. Oude Elberink¹⁵, 
17. J. Fernandez¹⁶, 
18. E. Gomes¹⁷, 
19. L. H. Garvey¹⁸,
20. J. Gooi¹⁹, 
21. M. Gotua²⁰, 
22. M. Grosber¹, 
23. P. Kauppi²¹, 
24. V. Kvedariene²², 
25. J. J. Laguna²³,
26. J. Makoswska²⁴, 
27. H. Mosbech¹⁸, 
28. A. Nakonechna²⁵, 
29. N. G. Papadopolous²⁶, 
30. J. Ring¹, 
31. A. Romano^11,27, 
32. H. Rockmann²⁸,
33. R. Sargur²⁹, 
34. L. Sedlackova³⁰, 
35. S. Sigurdardottir³¹, 
36. B. Schnyder³², 
37. T. Storaas³³, 
38. M. Torres⁷, 
39. M. Zidarn³⁴ and
40. I. Terreehorst³⁵

42. Summary

    The strongest and best-documented risk factor for drug hypersensitivity (DH) is the history of a previous reaction. Accidental exposures to drugs to may lead to severe or even fatal reactions in sensitised patients. Preventable prescription errors are common. They are often due to inadequate medical history or poor risk assessment of recurrence of drug reaction. Proper documentation is essential information for the doctor to make sound therapeutic decision. The European Network on Drug Allergy and Drug Allergy Interest Group of the European Academy of Allergy and Clinical Immunology have formed a task force and developed a drug allergy passport as well as general guidelines of drug allergy documentation.

How Affiliation Disclosure and Control Over User-Generated Comments Affects Consumer Health Knowledge and Behavior

Journal of Medical Internet Research Published on 19.07.16 in Vol 18, No 7 (2016): July

Original Paper

• David Christopher DeAndrea, PhD ; 
• Megan Ashley Vendemia, MA, MBA 

ABSTRACT

Background: More people are seeking health information online than ever before and pharmaceutical companies are increasingly marketing their drugs through social media.

Objective: The aim was to examine two major concerns related to online direct-to-consumer pharmaceutical advertising: (1) how disclosing an affiliation with a pharmaceutical company affects how people respond to drug information produced by both health organizations and online commenters, and (2) how knowledge that health organizations control the display of user-generated comments affects consumer health knowledge and behavior.

Measuring the Role and Effectiveness of Online and Social Media in Increasing the Outreach of a Scientific Conference

Journal of Medical Internet Research Published on 19.07.16 in Vol 18, No 7 (2016): July

Original Paper

• Marcel Winandy¹, PhD ; 
• Patty Kostkova^2*, PhD ; 
• Ed de Quincey^3*, PhD ; 
• Connie St Louis⁴, PhD ; 
• Martin Szomszor⁵, PhD 

ABSTRACT

Background: Social media promotion is increasingly adopted by organizers of industry and academic events; however, the success of social media strategies is rarely questioned or the real impact scientifically analyzed.

Objective: We propose a framework that defines and analyses the impact, outreach, and effectiveness of social media for event promotion and research dissemination to participants of a scientific event as well as to the virtual audience through the Web.

Efficacy and safety of bilastine in Japanese patients with perennial allergic rhinitis: A multicenter, randomized, double-blind, placebo-controlled, parallel-group phase III study

Article in Press

Kimihiro Okubo

, 

Minoru Gotoh

, 

Mikiya Asako

, 

Yasuyuki Nomura

, 

Michinori Togawa

, 

Akihiro Saito

,

Takayuki Honda

, 

Yoshihiro Ohashi

Open Access

DOI: http://dx.doi.org/10.1016/j.alit.2016.05.014

Article Info

• Abstract

• Full Text
• Images
• References
• Supplemental Materials

Abstract

Background

Bilastine, a novel non-sedating second-generation H1 antihistamine, has been approved in most European countries since 2010. This study aimed to evaluate the superiority of bilastine over placebo in Japanese patients with perennial allergic rhinitis (PAR).

Dr. Sergio Rosenzweig discusses how to diagnose a patient who has primary immunodefiency.

ACAAI COLA

Dr. Leonard Bielory discusses management of allergies of the eye

• ACAAICOLA